Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Science Advances|January 13, 2023
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin studyHelena A K Lapatto, Minna Kuusela, Aino Heikkinen, et al.
Scientific Reports|July 16, 2020
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetesRuchi Jain, Türküler Özgümüş, Troels Mygind Jensen, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levelsSteven J R Meex, Daphna Weissglas-Volkov, Carla J H van der Kallen, et al.
Cell Metabolism|February 20, 2018
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in HumansAdil Mardinoglu, Hao Wu, Elias Bjornson, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
Nature Communications|September 26, 2019
Genetic architecture of human plasma lipidome and its link to cardiovascular diseaseRubina Tabassum, Joel T Rämö, Pietari Ripatti, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and managementRobert A Hegele, Henry N Ginsberg, M John Chapman, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
European Heart Journal|February 14, 2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, M John Chapman, Ronald M Krauss, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Science Advances|January 13, 2023
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin studyHelena A K Lapatto, Minna Kuusela, Aino Heikkinen, et al.
Scientific Reports|July 16, 2020
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetesRuchi Jain, Türküler Özgümüş, Troels Mygind Jensen, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levelsSteven J R Meex, Daphna Weissglas-Volkov, Carla J H van der Kallen, et al.
Cell Metabolism|February 20, 2018
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in HumansAdil Mardinoglu, Hao Wu, Elias Bjornson, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
Nature Communications|September 26, 2019
Genetic architecture of human plasma lipidome and its link to cardiovascular diseaseRubina Tabassum, Joel T Rämö, Pietari Ripatti, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and managementRobert A Hegele, Henry N Ginsberg, M John Chapman, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
European Heart Journal|February 14, 2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, M John Chapman, Ronald M Krauss, et al.
Pageof 23